What's new

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 29, Status: Authorised

Mar 20, 2025 - 16:27
 0
Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Paratek acquires Optinose, rhinosinusitis spray Xhance in deal worth up to $330M

Next Article

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococ...

Related Posts

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

PSUSA/00000342/202407

PSUSA/00000342/202407

Feb 13, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),Mometasone (furoate),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0493/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 15, 2025  0